Literature DB >> 6982184

B cell lymphoproliferation in spontaneously diabetic BB Wistar rats.

T A Seemayer, W Schürch, N Kalant.   

Abstract

Ninety-six spontaneously diabetic BB Wistar rats were maintained for their natural life span and, at death, were autopsied together with 86 age-and sex-matched non-diabetic BB control rats. A 15% incidence of abdominal B cell lymphoproliferative lesions was documented in the diabetic rats compared with 1% incidence in the non-diabetic rats (p less than 0.005). The B cell lymphoproliferative process included minute mesenteric and omental aggregates of plasma cells and small lymphocytes (one rat), atypical partially fibrotic lymphoproliferative mesenteric nodules (three rats), and malignant lymphoma with features of immunoblastic sarcoma (eight rats) or plasma cell lymphoma (two rats). Cytoplasmic immunoglobulin was demonstrated in two of the four lymphomas examined by the peroxidase-antiperoxidase technique, thus confirming their B cell derivation. The striking incidence of B cell lymphoproliferation in this diabetic population is additional evidence of altered immunity in this animal model of insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Year:  1982        PMID: 6982184     DOI: 10.1007/BF00252852

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

2.  Thymus-antigen- and immunoglobulin- positive cells in lymph-nodes, thymus, and malignant lymphomas of NZB/NZW mice.

Authors:  J S Greenspan; G A Gutman; N Talal; I L Weissman; S Sugai
Journal:  Clin Immunol Immunopathol       Date:  1974-09

Review 3.  Reticulum cell neoplasm, type B, or the "Hodgkin's-like lesion" of the mouse.

Authors:  T B Dunn; M K Deringer
Journal:  J Natl Cancer Inst       Date:  1968-04       Impact factor: 13.506

4.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

Review 5.  Animal model of human disease. Diabetes mellitus.

Authors:  T A Seemayer; L L Oligny; G S Tannenbaum; H Goldman; E Colle
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

6.  Immuno-histological observations upon the development of reticulum cell sarcoma in the mouse.

Authors:  C R Taylor
Journal:  J Pathol       Date:  1976-04       Impact factor: 7.996

7.  The spontaneously diabetic Wistar rat. Metabolic and morphologic studies.

Authors:  A F Nakhooda; A A Like; C I Chappel; F T Murray; E B Marliss
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

8.  The BB diabetic rat. Profound T-cell lymphocytopenia.

Authors:  R Jackson; N Rassi; T Crump; B Haynes; G S Eisenbarth
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

9.  Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways.

Authors:  E Gleichmann; F van Elven; H Gleichmann
Journal:  Am J Clin Pathol       Date:  1979-10       Impact factor: 2.493

10.  Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex.

Authors:  E Colle; R D Guttmann; T Seemayer
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man.

Authors:  E B Marliss; A F Nakhooda; P Poussier; A A Sima
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

2.  Ciamexone, a highly selective immunomodulator--a tool for autoimmune diseases?

Authors:  U Bicker; K H Usadel
Journal:  Klin Wochenschr       Date:  1986-12-15

3.  Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages.

Authors:  G J Prud'homme; A Fuks; E Colle; T A Seemayer; R D Guttmann
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.